The Maharashtra Food & Drug Administration (FDA) has asked all drug controller authorities in the country to stop the use of a particular batch of drug INJ OROFER FCM following the death of a patient at a Mumbai hospital.

A person died at Saifee Hospital in Mumbai due to a suspected adverse drug reaction of the drug, said a senior official from FDA's Pune division on Wednesday.
Orofer FCM injection is used to treat iron deficiency anaemia.